Zobrazeno 1 - 10
of 63
pro vyhledávání: '"D. Ortendahl"'
Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States
Autor:
E Michael Lewiecki, Jesse D Ortendahl, Jacqueline Vanderpuye‐Orgle, Andreas Grauer, Jorge Arellano, Jeffrey Lemay, Amanda L Harmon, Michael S Broder, Andrea J Singer
Publikováno v:
JBMR Plus, Vol 3, Iss 9, Pp n/a-n/a (2019)
ABSTRACT In the United States, osteoporosis affects over 10 million adults, has high societal costs ($22 billion in 2008), and is currently being underdiagnosed and undertreated. Given an aging population, this burden is expected to rise. We projecte
Externí odkaz:
https://doaj.org/article/c3defc2ef2dd46939c503ff1199fcf1c
Autor:
Zac Wessler, Jesse D. Ortendahl, Amanda L Harmon, Tingjian Yan, Eunice Chang, Michael S. Broder
Publikováno v:
Current medical research and opinion. 38(2)
Objective Economic evaluations conducted to inform healthcare resource allocation often rely on quality-adjusted life years (QALYs) to measure therapeutic benefit. However, QALYs, with underlying health utilities estimated using the EQ-5D or SF-36, m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e9778ad6fa64a0e7abe4d870a82fd33
https://pubmed.ncbi.nlm.nih.gov/34775901
https://pubmed.ncbi.nlm.nih.gov/34775901
Autor:
Dasha Cherepanov, Michael S. Broder, Peter P. Toth, Allison L. Diamant, Amanda L Harmon, Jesse D. Ortendahl
Publikováno v:
Clinical Cardiology. 42:47-55
Aims Cardiovascular disease (CVD) mortality has decreased over 60% over the past 50 years in the United States; however, emerging data indicate CVD incidence may be rising because of shifting demographics, increasing risk factor prevalence, and compe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a31c2e86fa168ee76f00b6761298de5b
https://doi.org/10.1002/clc.23097
https://doi.org/10.1002/clc.23097
Publikováno v:
Journal of Medical Economics. 20:767-775
Cost effectiveness analysis (CEA) is a useful tool for estimating the value of an intervention in relation to alternatives. In cardiovascular disease (CVD), CEA is especially important, given the high economic and clinical burden. One key driver of v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c481feec8b96874af6281cd8c45891dc
https://doi.org/10.1080/13696998.2017.1336449
https://doi.org/10.1080/13696998.2017.1336449
Autor:
Sandra L. Chase, Alpesh Amin, Jesse D. Ortendahl, Shirin V. Sundar, Robert Stellhorn, Siddhesh A Kamat, Amanda L Harmon
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 76(6)
Purpose Costs associated with unplanned readmissions among patients with heart failure with and without hyponatremia were studied. Methods This study estimated the costs of patients hospitalized for heart failure (HF) discharged with or without corre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afaa5cff3131eed6c3ebb9fd1a411b9f
https://pubmed.ncbi.nlm.nih.gov/27019042
https://pubmed.ncbi.nlm.nih.gov/27019042
Autor:
Charles E. Begley, Shaun A. Hussain, Shaloo Gupta, Ibrahim Khilfeh, Jesse D. Ortendahl, Amanda L Harmon, R.L. Knoth, Tanya G K Bentley
Publikováno v:
EpilepsiaREFERENCES. 61(2)
Objective The burden of caregiving for persons with epilepsy (PWEs) has not been examined previously in the United States. We assessed the clinical impact and direct and indirect economic costs for caregivers of PWEs. Methods An internet survey of 50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::691f99cdf3dbe462d014fdefedb23c74
https://pubmed.ncbi.nlm.nih.gov/31953846
https://pubmed.ncbi.nlm.nih.gov/31953846
Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States
Autor:
Jacqueline Vanderpuye-Orgle, Andreas Grauer, Jeffrey Lemay, Jesse D. Ortendahl, E. Michael Lewiecki, Amanda L Harmon, Michael S. Broder, Andrea Singer, Jorge Arellano
Publikováno v:
JBMR Plus, Vol 3, Iss 9, Pp n/a-n/a (2019)
JBMR Plus
JBMR Plus
In the United States, osteoporosis affects over 10 million adults, has high societal costs ($22 billion in 2008), and is currently being underdiagnosed and undertreated. Given an aging population, this burden is expected to rise. We projected the fra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02bb89888bc96c708c630ed5b2e1cac8
https://doi.org/10.1002/jbm4.10192
https://doi.org/10.1002/jbm4.10192
Autor:
Jesse D. Ortendahl, Y. Tony Yang
Publikováno v:
Current medical research and opinion. 35(6)
Data related to the cost effectiveness of surgical interventions and catheter ablation is sparse. This model-based analysis assessed the clinical and economic trade-offs involved in using catheter ablation or the Cox maze procedure in treating patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::656e513e72596695642c634986c96555
https://pubmed.ncbi.nlm.nih.gov/30411990
https://pubmed.ncbi.nlm.nih.gov/30411990
Autor:
Amanda L Harmon, Alpesh Amin, Sandra L. Chase, Siddhesh A Kamat, Jesse D. Ortendahl, Shirin V. Sundar, Robert Stellhorn
Publikováno v:
Current medical research and opinion. 34(3)
Assess characteristics of patients with heart failure (HF) and hyponatremia (HN) using tolvaptan, a selective vasopressin V2-receptor antagonist, for sodium correction, and estimate the budget impact of tolvaptan use in a hospital.The Premier hospita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e1debc8e6274ae53589ab4946535099
https://pubmed.ncbi.nlm.nih.gov/29297709
https://pubmed.ncbi.nlm.nih.gov/29297709